The global Diagnostic Specialty Antibodies Market is steadily advancing, driven by the escalating prevalence of chronic and infectious diseases, rapid expansion of precision medicine, and surging demand for targeted biomarker detection. Valued at US$ 26.1 Billion in 2022, the market is projected to reach US$ 41.4 Billion by the end of 2031, expanding at a Compound Annual Growth Rate (CAGR) of...